These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 7078423)

  • 1. Thiazide for the postponement of postmenopausal bone loss.
    Transbøl I; Christensen MS; Jensen GF; Christiansen C; McNair P
    Metabolism; 1982 Apr; 31(4):383-6. PubMed ID: 7078423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of early postmenopausal bone loss: controlled 2-year study in 315 normal females.
    Christiansen C; Christensen MS; McNair P; Hagen C; Stocklund KE; Transbøl I
    Eur J Clin Invest; 1980 Aug; 10(4):273-9. PubMed ID: 6253303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of bone mineral loss in postmenopausal women by norethisterone.
    Abdalla HI; Hart DM; Lindsay R; Leggate I; Hooke A
    Obstet Gynecol; 1985 Dec; 66(6):789-92. PubMed ID: 4069480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors in response to treatment of early postmenopausal bone loss.
    Christiansen C; Mazess RB; Transbøl I; Jensen GF
    Calcif Tissue Int; 1981; 33(6):575-81. PubMed ID: 6275967
    [No Abstract]   [Full Text] [Related]  

  • 5. Actions of thiazide on vitamin D metabolism: a controlled therapeutic trial in normal women early in the postmenopause.
    Riis B; Christiansen C
    Metabolism; 1985 May; 34(5):421-4. PubMed ID: 3887100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continuous oestrogen-progestogen treatment and bone metabolism in post-menopausal women.
    Riis BJ; Johansen J; Christiansen C
    Maturitas; 1988 May; 10(1):51-8. PubMed ID: 3041248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathophysiological mechanisms of estrogen effect on bone metabolism. Dose-response relationships in early postmenopausal women.
    Christiansen C; Christensen MS; Larsen NE; Transbøl IB
    J Clin Endocrinol Metab; 1982 Dec; 55(6):1124-30. PubMed ID: 7130340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone mass in postmenopausal women after withdrawal of oestrogen/gestagen replacement therapy.
    Christiansen C; Christensen MS; Transbøl I
    Lancet; 1981 Feb; 1(8218):459-61. PubMed ID: 6110089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcium supplementation and postmenopausal bone loss.
    Nilas L; Christiansen C; Rødbro P
    Br Med J (Clin Res Ed); 1984 Oct; 289(6452):1103-6. PubMed ID: 6435793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Total and local bone mineral during estrogen treatment: a placebo controlled trial.
    Gotfredsen A; Riis BJ; Christiansen C
    Bone Miner; 1986 Apr; 1(2):167-73. PubMed ID: 3334206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of 1,25-dihydroxy-vitamin D3 in itself or combined with hormone treatment in preventing postmenopausal osteoporosis.
    Christiansen C; Christensen MS; Rødbro P; Hagen C; Transbøl I
    Eur J Clin Invest; 1981 Aug; 11(4):305-9. PubMed ID: 6795047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of natural estrogen/gestagen and thiazide on coronary risk factors in normal postmenopausal women. A 2-year double-blind placebo study.
    Christiansen C; Christensen MS; Hagen C; Stocklund KE; Transbøl I
    Acta Obstet Gynecol Scand; 1981; 60(4):407-12. PubMed ID: 7282308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of thiazide- and loop-diuretics, alone or in combination, on calcitropic hormones and biochemical bone markers: a randomized controlled study.
    Rejnmark L; Vestergaard P; Heickendorff L; Andreasen F; Mosekilde L
    J Intern Med; 2001 Aug; 250(2):144-53. PubMed ID: 11489064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coherence therapy does not prevent axial bone loss in osteoporotic women: a preliminary comparative study.
    Pacifici R; McMurtry C; Vered I; Rupich R; Avioli LV
    J Clin Endocrinol Metab; 1988 Apr; 66(4):747-53. PubMed ID: 3126214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of calcium supplementation on bone loss in postmenopausal women.
    Reid IR; Ames RW; Evans MC; Gamble GD; Sharpe SJ
    N Engl J Med; 1993 Feb; 328(7):460-4. PubMed ID: 8421475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does calcium supplementation prevent postmenopausal bone loss? A double-blind, controlled clinical study.
    Riis B; Thomsen K; Christiansen C
    N Engl J Med; 1987 Jan; 316(4):173-7. PubMed ID: 3540668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of bone loss induced by thyroxine suppressive therapy in postmenopausal women: the effect of calcium and calcitonin.
    Kung AW; Yeung SS
    J Clin Endocrinol Metab; 1996 Mar; 81(3):1232-6. PubMed ID: 8772604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hydrochlorothiazide reduces loss of cortical bone in normal postmenopausal women: a randomized controlled trial.
    Reid IR; Ames RW; Orr-Walker BJ; Clearwater JM; Horne AM; Evans MC; Murray MA; McNeil AR; Gamble GD
    Am J Med; 2000 Oct; 109(5):362-70. PubMed ID: 11020392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of calcium supplementation on forearm bone mineral content in postmenopausal women: a prospective, sequential controlled trial.
    Polley KJ; Nordin BE; Baghurst PA; Walker CJ; Chatterton BE
    J Nutr; 1987 Nov; 117(11):1929-35. PubMed ID: 3316538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A calcium-collagen chelate dietary supplement attenuates bone loss in postmenopausal women with osteopenia: a randomized controlled trial.
    Elam ML; Johnson SA; Hooshmand S; Feresin RG; Payton ME; Gu J; Arjmandi BH
    J Med Food; 2015 Mar; 18(3):324-31. PubMed ID: 25314004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.